State Street’s Zosano Pharma Corporation ZSAN Stock Holding History

State Street’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,467	Closed	-$98K	–	5039
2022 Q1	$98K	Buy	12,467 +498	+4%	+$5.48K	﹤0.01%	4649
2021 Q4	$197K	Hold	11,969	–	–	﹤0.01%	4361
2021 Q3	$301K	Hold	11,969	–	–	﹤0.01%	4196
2021 Q2	$398K	Buy	+11,969	New	+$386K	﹤0.01%	3945

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

State Street's ZSAN Position: Q2 2022 in Review

State Street sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 12,467 shares — an estimated $98K sold.

State Street first reported a position in ZSAN in Q2 2021 and held it in 4 quarters. The position peaked at $398K in Q2 2021. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

State Street reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
State Street sold 12,467 Zosano Pharma Corporation shares in Q2 2022, an estimated $98K.
State Street first reported a position in Zosano Pharma Corporation in Q2 2021 and held it in 4 quarters.
State Street's Zosano Pharma Corporation position peaked at $398K in Q2 2021.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on State Street's 13F filing for Q2 2022, filed 15 Aug 2022.